Mini heart pump trial halted early, but shows promise for advanced heart failure
Disease control
Terminated
This study tested a small heart pump called the HeartWare MVAD in 11 people with severe heart failure. The goal was to see if the device is safe and helps patients live longer. The trial was stopped early, but it measured how many patients survived for 6 months and 2 years.
Phase: NA • Sponsor: Medtronic Cardiac Rhythm and Heart Failure • Aim: Disease control
Last updated May 06, 2026 16:15 UTC